Voyager Acquisition Corp./Cayman Islands
VACHNasdaqHealthcare · Biological Products, (No Diagnostic Substances) · E9 · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | |
|---|---|---|---|
| Revenue | — | — | — |
| Operating income | −$1.8M | −$702,959 | −$5,000 |
| Net income | $9.0M | $4.1M | −$5,000 |
| Total assets | $270.1M | $259.8M | $71,680 |
| Total liabilities | $13.3M | $12.1M | $76,680 |
| Equity | −$13.1M | −$11.4M | −$5,000 |
| EPS (diluted) | — | $0.24 | $-5000.00 |
| Shares out. | 25.3M | 6.3M | 1 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −68.4%
- Return on assets
- 3.3%
- Return on capital (ROCE)
- −0.7%
- Liabilities / assets
- 4.9%
- Debt / equity
- —
- Book value / share
- $-0.52
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- 117.1%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -1.26distress
- Accruals / assets
- 3.5%clean
- Piotroski F-Score
- 2/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 severe● 1 warning● 2 good- Negative shareholder equity
- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 15, 2026
- NT 10-Qmissed a reporting deadline ↗Sep 23, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Magnetar Financial LlcPassive (13G)May 18, 2026
- First Trust Capital Management L.P.Passive (13G)May 15, 2026
- Goldman Sachs Group IncPassive (13G)May 11, 2026
- Berkley W R CorpPassive (13G)May 8, 2026
- Wolverine Asset Management LlcPassive (13G)Apr 15, 2026
- Lmr Partners LlpPassive (13G)Feb 17, 2026
- Aqr Capital Management LlcPassive (13G)May 14, 2025
- Barclays PlcPassive (13G)Mar 21, 2025
- Ya Ii Pn, Ltd.Passive (13G)Jan 13, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1,715 | 1.0 | -7.6% |
| Apr 30, 2026 | 1,856 | 1.0 | -44.5% |
| Apr 15, 2026 | 3,342 | 1.0 | -20.4% |
| Mar 31, 2026 | 4,199 | 1.0 | -79.6% |
| Mar 13, 2026 | 20,575 | 1.0 | +316.8% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Entered a material agreement · New financial obligation · Unregistered equity sale · Regulation FD disclosureMay 29, 2026
- Shareholder vote · Regulation FD disclosure · Other material eventMar 18, 2026
- Regulation FD disclosureFeb 27, 2026
- Entered a material agreementFeb 3, 2026
- Entered a material agreementOct 21, 2025
- Regulation FD disclosureSep 5, 2025
- Entered a material agreementJul 16, 2025
- Entered a material agreement · Regulation FD disclosureApr 23, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 8-KMay 29, 2026
- 10-QMay 20, 2026
- SCHEDULE 13G/AMay 18, 2026
- SCHEDULE 13G/AMay 15, 2026
- NT 10-QMay 15, 2026
- SCHEDULE 13G/AMay 11, 2026
- SCHEDULE 13G/AMay 8, 2026
- SCHEDULE 13G/AApr 15, 2026
- 10-K/AApr 2, 2026
- 425Mar 18, 2026
- 8-KMar 18, 2026
- 425Mar 12, 2026
- 10-KMar 10, 2026
- 8-KFeb 27, 2026
- 425Feb 27, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.